Gastroenterologisches Sonographie-Update 2011

Dietrich,

doi:10.1024/1661-8157/a000836

Cited by 8 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…8). Subepithelial lesions so far are not part of the EFSUMB guidelines 36414243. Oncological principles and locoregional complications have to be regarded 444546474849…”

Section: Gastrointestinal Tractmentioning

confidence: 99%

Contrast-Enhanced Endoscopic Ultrasound

Dietrich

Sharma

Hocke³

2012

Endosopic Ultrasound

View full text Add to dashboard Cite

The European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) introduced guidelines on the use of contrast-enhanced ultrasound (CEUS) in 2004. This EFSUMB-document focused mainly on liver applications. However, new applications extending beyond the liver were developed thereafter. Increased interest in recent years in CEUS technique and in the application of CEUS in novel fields like endoscopic ultrasound (EUS) has revolutionized indications and applications. As a result, the EFSUMB initiated a new update of the guidelines in 2011 to include this additional knowledge. Some of the contrast-enhanced EUS (CE-EUS) indications are established, whereas others are preliminary; these latter indications are categorized as emergent CEUS applications since the available evidence is insufficient for general recommendation. This article focuses on the use of CE-EUS in various clinical settings. The reader will get an overview of current indications and possible applications of CE-EUS. This involves the introduction of different contrast studies including color Doppler techniques (known as contrast-enhanced high mechanical index endosonography or CEHMI-EUS) as well as more modern high-resolution contrast-enhanced techniques (known as contrast-enhanced low mechanical index endosonography or CELMI EUS).

show abstract

“…8). Subepithelial lesions so far are not part of the EFSUMB guidelines 36414243. Oncological principles and locoregional complications have to be regarded 444546474849…”

Section: Gastrointestinal Tractmentioning

confidence: 99%